Establishing the European Virtual Physiological Human Institute

empiricaTo provide strong support for both the European Union Virtual Physiological Human (VPH) research initiative and the global "Physiome" community, the process to establish a European VPH Institute has now officially started. The VPH initiative is part of the worldwide public domain effort to provide a computational framework for understanding human physiology. It aims to develop integrative models at all levels of biological organisation, from genes to the whole organism via gene regulatory networks, protein pathways, integrative cell function, and tissue and whole organ structure/function relations. Through its 7th Framework Research Programme (FP7), the European Commission has initiated and facilitated such research.

The idea to establish a VPH Institute dates back to the STEP VPH Research roadmap where it was suggested to establish a European Institute dedicated entirely to the Virtual Physiological Human (VPH). This idea has been re-proposed and expanded in the recent "Vision & Strategy" document of the VPH Network of Excellence, and has received overwhelmingly positive reaction by the research community, with nearly 300 signatures from over 30 countries. The Pro Tempore Board of Directors has now formally entered the formation process, which should be completed before the end of 2010. empirica's Dr. Karl Stroetmann has been asked to join this Board as expert for the clinical and socio-economic impact assessment of VPH Technology.

empirica is a beneficiary to three VPH-related projects:

  • ARGOS eHealth: an EU-USA project, funded by the European Commission’s DG External Relations, for a Transatlantic Observatory for Meeting Global Health Policy Challenges through ICT-Enabled Solutions, focusing as one of three topics on VPH issues
  • NMS-Physiome: A project on tools to develop the NeuroMusculoSkeletal Physiome – VPHOP-SIMBIOS cooperation. EU-funded cooperation of the worldwide largest research projects focusing on simulating the musculoskeletal apparatus, the Osteoporotic Virtual Physiological Human (VPHOP) integrated European project and the Center for Physics-based Simulation of Biological Structures (SIMBIOS) (at Stanford University, USA), funded by the USA National Institutes of Health
  • VPHOP: Osteoporotic Virtual Physiological Human EU FP7 large-scale integrating project: a multiscale modelling and simulation technology will be developed to predict the strength of a patient’s bones, how this strength is likely to change over time, and the probability that he will overload his bones during daily life. The various modelling technologies developed will be assessed in terms of clinical and socio-economic impact and safety on small cohorts of patients enrolled at four different clinical institutions, providing the factual basis for effective clinical and industrial exploitation.

empirica expects to strongly contribute to future endeavours in this fascinating research field and thereby also to help guide its outcomes towards realistic and beneficial clinical applications.

Related news articles:

About empirica
empirica Communication and Technology Research is a private research institute founded in 1988 and based in Bonn, Germany. It specialises in communication and information technology related research and consultancy to clients in both the private and public sector. Its body of ex-pertise ranges from long-term RTD roadmapping, policy and strategy development to pilot trials and EU-wide representative market research. The company has gained a strong profile in the practical development, pilot-testing and market validation of IST-based healthcare services. It observes and interprets market trends and evaluates the socio-economic impact of eHealth ap-plications. In addition, it regularly conducts foresight exercises, representative surveys and compiles data bases of good practice case studies with the support of a dense network of con-tacts in government, industry and academia. For further information, please visit www.empirica.com.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...